期刊
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
卷 133, 期 44, 页码 17524-17527出版社
AMER CHEMICAL SOC
DOI: 10.1021/ja208427j
关键词
-
资金
- DHA
- National Cancer Institute Center for Cancer Nanotechnology Excellence (CCNE) Initiative at Northwestern University [U54CA119341]
We have investigated the efficacy of graphene oxide (GO) in modulating enzymatic activity. Specifically, we have shown that GO can act as an artificial receptor and inhibit the activity of alpha-chymotrypsin (ChT), a serine protease. Most significantly, our data demonstrate that GO exhibits the highest inhibition dose response (by weight) for ChT inhibition compared with all other reported artificial inhibitors. Through fluorescence spectroscopy and circular dichroism studies, we have shown that this protein receptor interaction is highly biocompatible and conserves the protein's secondary structure over extended periods (>24 h). We have also explored GO-enzyme interactions by controlling the ionic strength of the medium, which attenuates the host guest electrostatic interactions. These findings suggest a new generation of enzymatic inhibitors that can be applied to other complex proteins by systematic modification of the GO functionality.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据